![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1397.jpg)
Takei H, et al. Breast Cancer Res Treat. 2012;133:227–236
HRQOL was better in Japanese postmenopausal
women treated with tamoxifen than those
treated with exemestane or anastrozole. HRQOL
and AEs were similar with exemestane and
anastrozole.
Less local treatment: where is the limit?
Side effects